Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Novel regulator of enterohepatic bile acid signaling protects against hypercholesterolemia.

Dawson PA.

Cell Metab. 2013 Jun 4;17(6):816-8. doi: 10.1016/j.cmet.2013.05.005.

2.

Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

Vergnes L, Lee JM, Chin RG, Auwerx J, Reue K.

Cell Metab. 2013 Jun 4;17(6):916-28. doi: 10.1016/j.cmet.2013.04.007.

3.

Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.

Reue K, Lee JM, Vergnes L.

Dig Dis. 2015;33(3):307-13. doi: 10.1159/000371649. Epub 2015 May 27.

4.
5.
6.

Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era?

Angelin B, Eriksson M, Rudling M.

Curr Opin Lipidol. 1999 Jun;10(3):269-74. Review.

PMID:
10431663
7.

Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.

Lukovac S, Los EL, Stellaard F, Rings EH, Verkade HJ.

Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G520-31. doi: 10.1152/ajpgi.00091.2009. Epub 2009 Jul 16.

8.

The Diet1 locus confers protection against hypercholesterolemia through enhanced bile acid metabolism.

Phan J, Pesaran T, Davis RC, Reue K.

J Biol Chem. 2002 Jan 4;277(1):469-77. Epub 2001 Oct 26.

9.

Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.

Reue K, Lee JM, Vergnes L.

Curr Opin Lipidol. 2014 Apr;25(2):140-7. doi: 10.1097/MOL.0000000000000060. Review.

10.

PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.

He J, Nishida S, Xu M, Makishima M, Xie W.

Gastroenterology. 2011 Jun;140(7):2095-106. doi: 10.1053/j.gastro.2011.02.055. Epub 2011 Feb 24.

11.

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA.

Cell Metab. 2005 Oct;2(4):217-25.

12.

FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.

Shin DJ, Osborne TF.

J Biol Chem. 2009 Apr 24;284(17):11110-20. doi: 10.1074/jbc.M808747200. Epub 2009 Feb 23.

13.

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F.

Cell Metab. 2013 Feb 5;17(2):225-35. doi: 10.1016/j.cmet.2013.01.003.

14.

Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbits.

Xu G, Pan LX, Erickson SK, Forman BM, Shneider BL, Ananthanarayanan M, Li X, Shefer S, Balasubramanian N, Ma L, Asaoka H, Lear SR, Nguyen LB, Dussault I, Suchy FJ, Tint GS, Salen G.

J Lipid Res. 2002 Jan;43(1):45-50.

15.

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.

Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B, Jones SA.

Genes Dev. 2003 Jul 1;17(13):1581-91. Epub 2003 Jun 18.

16.

Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits.

Xu G, Shneider BL, Shefer S, Nguyen LB, Batta AK, Tint GS, Arrese M, Thevananther S, Ma L, Stengelin S, Kramer W, Greenblatt D, Pcolinsky M, Salen G.

J Lipid Res. 2000 Feb;41(2):298-304.

17.

Coordinate regulation of bile acid biosynthetic and recovery pathways.

Torchia EC, Cheema SK, Agellon LB.

Biochem Biophys Res Commun. 1996 Aug 5;225(1):128-33.

PMID:
8769105
18.

Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.

Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F.

Lab Invest. 2010 Oct;90(10):1457-67. doi: 10.1038/labinvest.2010.107. Epub 2010 Jun 7.

19.

Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi.

Shoda J, Oda K, Suzuki H, Sugiyama Y, Ito K, Cohen DE, Feng L, Kamiya J, Nimura Y, Miyazaki H, Kano M, Matsuzaki Y, Tanaka N.

Hepatology. 2001 May;33(5):1194-205.

PMID:
11343249
20.

Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.

Einarsson K, Ericsson S, Ewerth S, Reihnér E, Rudling M, Ståhlberg D, Angelin B.

Eur J Clin Pharmacol. 1991;40 Suppl 1:S53-8.

PMID:
2044645
Items per page

Supplemental Content

Write to the Help Desk